Narrative review: senescent skeletal stem cells as a regenerative bottleneck in age-related bone, joint and disc degeneration
This narrative review argues that senescence of skeletal stem and progenitor cells is a compartment-specific therapeutic bottleneck shared by osteoporosis, osteoarthritis and intervertebral disc degeneration, and compares candidate regenerative strategies. [1]
Automatic summary · not editorially reviewed
The key findings
The review proposes that osteoporosis, osteoarthritis and intervertebral disc degeneration share a common regenerative failure of endogenous stem and progenitor cells. [1]
The review treats senescence mechanisms as interlocking processes that reshape skeletal niches. [1]
The review compares senolytics, senomorphics, metabolic and mitochondrial regulators, cell rejuvenation, extracellular vesicle engineering, biomaterials and gene-based delivery platforms. [1]
The source at a glance
- Study type / format
- Narrative review (abstract only)
- Population / context
- Skeletal stem and progenitor cell populations in age-related bone, joint and disc degeneration
- Summary based on
- Study abstract
- Original publication
- September 27, 2026
Shared regenerative failure across three skeletal disorders
The review starts from the observation that osteoporosis, osteoarthritis and intervertebral disc degeneration are usually managed as anatomically separate disorders. It proposes they share a common regenerative failure: endogenous stem and progenitor cells lose renewal capacity, acquire inflammatory secretory programs and become less able to rebuild damaged matrix. The review covers senescence in bone marrow mesenchymal stem/stromal cells, skeletal stem cells, hematopoietic stem cells, cartilage progenitor cells, synovial mesenchymal stromal cells and disc-derived progenitor populations.
Supporting source [1]
Mechanisms and disease-specific progenitor compartments
The review discusses telomere-associated DNA damage, mitochondrial and oxidative stress, nutrient- and mechanosensing pathways, epigenetic remodeling, dysregulated autophagy and mitophagy, and the senescence-associated secretory phenotype as interlocking mechanisms that reshape skeletal niches. Disease-specific sections then examine how senescent progenitor compartments are proposed to drive osteoporosis, osteoarthritis and intervertebral disc degeneration through impaired osteogenesis or chondrogenesis, matrix catabolism, inflammatory vesicle signaling and maladaptive mechanical feedback.
Supporting source [1]
Candidate strategies and translation requirements
From a regenerative medicine perspective, the review compares senolytics, senomorphics, metabolic and mitochondrial regulators, cell rejuvenation, extracellular vesicle engineering, biomaterials and gene-based delivery platforms. It concludes that stem/progenitor cell senescence should be treated not simply as a biomarker of aging but as a compartment-specific therapeutic bottleneck. Translation would require rigorous cell identity, multi-parameter senescence assays, disease-stage stratification, and therapies that restore regenerative competence without suppressing physiological repair.
Supporting source [1]
How to interpret this
This is a narrative review; the abstract reports no systematic search, sample size, follow-up or outcome data, and the full text was not reviewed. Proposed mechanisms and translational strategies are not established treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang X, Huang Y, Zhu T, Qiu H. · europepmc.org · September 27, 2026